threonine has been researched along with Lupus Nephritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiepe, F; Radbruch, A | 1 |
| Lu, LD; Ruggeri, BA; Seavey, MM; Stump, KL; Wallace, NH | 1 |
1 review(s) available for threonine and Lupus Nephritis
| Article | Year |
|---|---|
Plasma cells as an innovative target in autoimmune disease with renal manifestations.
Topics: Autoantibodies; Autoimmune Diseases; B-Lymphocytes; Boronic Acids; Bortezomib; Glomerulonephritis; Humans; Immunologic Memory; Immunosuppressive Agents; Kidney Diseases; Lupus Nephritis; Oligopeptides; Peptides; Plasma Cells; Proteasome Inhibitors; Threonine | 2016 |
1 other study(ies) available for threonine and Lupus Nephritis
| Article | Year |
|---|---|
Novel, orally active, proteasome inhibitor, delanzomib (CEP-18770), ameliorates disease symptoms and glomerulonephritis in two preclinical mouse models of SLE.
Topics: Animals; Antibodies, Antinuclear; Boronic Acids; Cytokines; Disease Models, Animal; Drug Administration Routes; Female; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Spleen; Threonine | 2012 |